$NKE

Nike’s First Quarter Revenue Reaches $11.2 Billion as Pace Transformation Plan Officially Takes Effect

Nike (NKE) reported Q1 FY2027 revenue of $11.2B, down 4% YoY, with net profit declining 2% to $712M. The company launched its Pace transformation plan, restructuring into three regions and aiming for $2.5B in savings by FY2031. Despite improved gross margin, Nike forecasted a high-single-digit revenue decline for FY2027.

Original reporting
Published Oct 2, 2026, 7:01 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 2, 2026, 8:11 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Nike’s First Quarter Revenue Reaches $11.2 Billion as Pace Transformation Plan Officially Takes Effect — source image
Decision brief

The 30-second read

$NKEBearishHigh
01

Why it matters

The earnings miss and cautious FY2027 outlook are likely to trigger a short‑term sell‑off, though the announced cost‑saving program could support a longer‑term rebound.

02

Market read

Nike's results are a key barometer for the consumer discretionary sector and can move broader market sentiment.

03

What to watch

Potential upside from the new India campus and supply‑chain modernization may not be fully priced yet.

Relevance 8/10Novelty 9/10Timing: after‑hours release

Background

Nike's Q1 FY2027 earnings release includes a modest profit decline, a revenue miss, and a new Pace transformation plan with $2.5B cumulative savings target.

Company-level read

Ticker impact

$NKEBearishMedium confidence
Context

Nike reported Q1 FY2027 revenue of $11.2B (down 4% YoY) and net profit of $712M (down 2% YoY) and guided a high‑single‑digit revenue decline for FY2027.

Expected impact

likely pressure as the market prices in the revenue decline guidance and restructuring charges

Evidence & confidence

Revenue fell year‑over‑year and guidance signals a decline, while $300M of restructuring charges are expected in FY2027, creating downside risk.

Market effects

Apparel and footwear sector may see broader pressure as Nike signals slower growth in Greater China.

Greater China exposure could weigh on Asian consumer stocks.

Nike's size means its guidance can influence global consumer discretionary sentiment.

Counterpoint

The restructuring could unlock long‑term cost savings, offering a buying opportunity if the market overreacts.

Key entities

  • Nike

    Global athletic apparel and footwear manufacturer.

Related articles

$NKEHighAI 9/10

Why is Nike stock tumbling today?

Nike (NKE) stock dropped 9.6% after reporting mixed Q1 2027 results: earnings beat estimates ($0.48 vs. $0.44) but revenue missed ($11.21B vs. $11.35B). Full-year guidance was significantly lower than expected, with revenue projected to fall in the high single digits and EPS between $1.15 and $1.35. China sales declined 26%, and the company announced a restructuring plan targeting $2.5B in savings by 2031.

$NKEMed

Nike, Synaptics And 3 Stocks To Watch Heading Into Friday

Nike (NKE) reported mixed Q1 results, missing revenue estimates but beating earnings. Synaptics (SYNA) agreed to be acquired by ON Semiconductor (ON) for $123 per share. Edwards Lifesciences (EW) received FDA approval for a pediatric valve. AsiaStrategy (SORA) and Mangoceuticals (MGRX) made announcements, causing after-hours price swings.

$NKEHighAI 8/10

NKE Q3 Deep Dive: Deliberate Resets Weigh on Revenue as Nike Focuses on Long-Term Health

Nike (NKE) reported Q3 2026 revenue of $11.21B, down 4.3% YoY, missing estimates. EPS of $0.48 beat forecasts. Management cited deliberate reductions in Sportswear and Jordan volumes, China inventory cleanup, and underperformance in lifestyle categories. Forward guidance reflects cautious optimism with continued revenue and margin pressure. Nike trades at $32.09, down from $35.22 pre-earnings.

$NKEHighAI 8/10

Nike’s Growth Problem is Bigger than One Bad Quarter

Nike (NYSE:NKE) reported a 4% revenue decline to $11.2B in Q1 FY2027, missing estimates. EPS of $0.48 beat expectations. The company forecasted a high-single-digit revenue drop for FY2027, causing the stock to fall. Revenue has declined from $51.4B in FY2024 to $46.4B in FY2026, with operating income dropping to $3.7B. Challenges include weak product innovation, competition, and a 26% sales drop in China. North American sales rose 2%, and margins improved.